Ticker Details
Lantheus Holdings, Inc. Lantheus Holdings Inc develops diagnostic products for the healthcare sector. Its chief product is imaging agents used by physicians in diagnostic procedures such as cardiac ultrasounds and X-ray imaging.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$4.9B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.77 | 2.28%
Avg Daily Range (30 D):	$0.70 | 1.03%
Avg Daily Range (90 D):	$0.96 | 1.58%

Institutional Daily Volume
Avg Daily Volume:	.58M
Avg Daily Volume (30 D):	.6M
Avg Daily Volume (90 D):	.82M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	42
Avg Trade Size (Sh.) (90 D):	46

Institutional Trades
Total Institutional Trades:	5,810
Avg Institutional Trade:	$3.41M
Avg Institutional Trade (30 D):	$4.05M
Avg Institutional Trade (90 D):	$4.54M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	3

Market Closing Trades
Avg Closing Trade:	$5.82M
Avg Closing Trade (30 D):	$7.91M
Avg Closing Trade (90 D):	$9.12M
Avg Closing Volume:	105.89K

News

Feb 20, 2026 @ 3:55 PM PSMA-Targeted Therapy & Radiodiagnostics Competito... Source: Researchandmarkets.Com

Feb 12, 2026 @ 1:00 PM Lantheus to Host Fourth Quarter and Full Year 2025... Source: Na

Jan 2, 2026 @ 1:00 PM Lantheus Announces Closing of SPECT Business Sale ... Source: Na

Dec 23, 2025 @ 11:25 PM Lantheus Exit: $28 Million Sale Comes as Earnings ... Source: Jonathan Ponciano

Nov 13, 2025 @ 10:40 PM Bragar Eagel & Squire is Investigating Certain Off... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$2.45	$.41	$1.15
Diluted EPS	$2.36	$.41	$1.12
Revenue	$1.53B	$384.01M	$378.05M
Gross Profit	$949.62M	$222.37M	$241.01M
Net Income / Loss	$167.68M	$27.77M	$78.76M
Operating Income / Loss	$347.52M	$43.62M	$87.97M
Cost of Revenue	$576.31M	$161.65M	$137.03M
Net Cash Flow	$-484.35M	$-313.56M	$-242.95M
PE Ratio	31.36